Spotfire Clinical Trials Analysis
Spotfire Clinical Trials Analysis allows pharmaceutical companies to make important business decisions about their drug development candidates and strategies. Explore how Spotfire enables companies to fail early by spotting safety issues earlier in the development process by providing a faster and more flexible environment to explore and understand key aspects of safety and efficacy in their studies.
The Solution:
Spotfire enables clinical pharmacologists to dynamically explore drug safety in their clinical studies.
- Identify patterns and trends in safety data that will elucidate risk
- Visual representations of adverse event, lab safety, demographic and concomitant medications in one analysis environment
- Rapid ask and answer iterations allow for broader analysis and more time spent on the most important areas
The Solution:
Spotfire helps data monitors to systematically review trials data to identify and resolve incorrect data, resulting in faster lock-down of the trial database.
- Outliers and exceptions can easily be visualized – in context
- Explore patterns and trends in outliers, missing data, and failed test results
The Solution:
Spotfire empowers translational research, by combining genomic, demographic, and safety data to enable new insights into safety, efficacy, and patient populations.
- Integration and analysis of clinical and molecular data
- Correlations between gene or protein expression and safety profiles
- Flexibility to adapt to new technologies and methodologies
The Solution:
For the effective communication of clinical data across functional areas, and in journals, presentations, and regulatory submissions, Spotfire enables point-and-click creation of advanced graphics and seamless integration with existing exploratory, presentation, and production reporting environments.
- Reduce graphic development time and cost
- Promote more effective communication across all review and reporting groups
- Realize more efficient resource utilization
